Pliant Therapeutics, Inc. (PLRX)
1.29
+0.01
(+0.78%)
USD |
NASDAQ |
Jan 16, 16:00
1.295
0.00 (0.00%)
Pre-Market: 20:00
Pliant Therapeutics EPS Diluted (Quarterly): -0.4283 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.079 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.30M |
| Total Expenses (Quarterly) | 26.30M |
| Enterprise Value | -102.67M |
| Earnings Yield | -222.3% |
| Normalized Earnings Yield | -222.43 |